Torrent Pharma reports 56.45 percent jump in net profit to Rs 449 crore in Q4
Advertisement
New Delhi: Torrent Pharmaceuticals Ltd witnessed a significant surge in its consolidated net profit, soaring by 56.45% to reach Rs 449 crore in the March quarter, buoyed by increased revenue. This marks a notable increase from the consolidated net profit of Rs 287 crore reported during the corresponding period of the previous fiscal year, as stated by Torrent Pharmaceuticals in a regulatory filing.
Consolidated revenue from operations in the fourth quarter of FY24 stood at Rs 2,745 crore as against Rs 2,491 crore in the year-ago period, it added.
India revenue was at Rs 1,380 crore, up 10 per cent while the same for Brazil was at Rs 372 crore, registering a growth of 17 per cent, and Germany was at Rs 280 crore, up 11 per cent in the quarter, the company said.
On the other hand, US business revenue was at Rs 262 crore, down 6 per cent, it added.
For the fiscal ended March 31, 2024 consolidated net profit was at Rs 1,656 crore as compared to Rs 1,245 crore in the previous year, the company said.
Consolidated revenue from operations in FY24 stood at Rs 10,728 crore as compared to Rs 9,620 crore in FY23.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.